Low frequency of factor V Leiden and prothrombin G20210A mutations in patients with hepatic venous outflow tract obstruction in northern India: A case-control study

Indian Journal of Gastroenterology

Volumn 24, Issue 5, 2005, Pages 211-215

  Kumar, Sirish I ^a   Kumar, Ashish ^a   Srivastava, Srikant ^a   Saraswat, Vivek A ^a   Aggarwal, Rakesh ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; GENOMIC DNA; PROTHROMBIN; BLOOD CLOTTING FACTOR 5;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INDIA; INFERIOR CAVA VEIN OBSTRUCTION; LIVER VEIN OBSTRUCTION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOSIS; CASE CONTROL STUDY; ETHNOLOGY; GENETICS; LIVER VEIN THROMBOSIS; MIDDLE AGED; MUTATION;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; FACTOR V; FEMALE; HEPATIC VEIN THROMBOSIS; HUMANS; INDIA; MALE; MIDDLE AGED; MUTATION; PROTHROMBIN;

EID: 33644800098     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Ludwig J, Hashimoto E, McGill DB, van Heerden JA. Classification of hepatic venous outflow obstruction: ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc 1990;65:51-5.
2. Okuda K. Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol 2001;16:1179-83.
3. Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 2002;22:15-26.
4. De BK, Biswas PK, Sen S, Das D, De KK, Das U, et al . Management of the Budd-Chiari syndrome by balloon cavoplasty. Indian J Gastroenterol 2001;20:151-4.
5. Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, et al . Hepatic outflow obstruction (Budd-Chiari syndrome). Medicine 1994;73:21-36.
6. Sambrook J, Russel DW. Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor Laboratory: Cold Spring Harbor, NY. 2001.
7. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, et al . Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-7.
8. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
9. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by a poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 1993;90:1004-8.
10. Dahlback B, Hildebrand B. Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V. Proc Natl Acad Sci USA 1994;91:1396-400.
11. Deltenre P, Denninger MH, Hillaire S, Guillin MC, Casadevall N, Briere J, et al . Factor V Leiden related Budd-Chiari syndrome. Gut 2001;48:264-8.
12. Janssen HL, Meinardi JR, Vleggaar FP, van Uum SH, Haagsma EB, van Der Meer FJ, et al . Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study. Blood 2000;96:2364-8.
13. Mahmoud AE, Elias E, Beauchamp N, Wilde JT. Prevalence of the factor V Leiden mutation in hepatic and portal vein thrombosis. Gut 1997;40:798-800.
14. Terabayashi H, Okuda K, Nomura F, Ohnishi K, Wong P. Transformation of inferior venacaval thrombosis to membranous obstruction in a patient with the lupus anticoagulant. Gastroenterology 1986;91:219-24.
15. Ishiguchi T, Fukatsu H, Itoh S, Shimamoto K, Sakuma S. Budd-Chiari syndrome with long segmental inferior vena cava obstruction: treatment with thrombolysis, angioplasty and intravascular stents. J Vasc Interv Radiol 1992;3:421-5.
16. Feng B, Xu K, Jiang H. Relationship between factor V Leiden mutation and Chinese Budd-Chiari syndrome and its clinical significance. Zhonghua Yi Xue Za Zhi 2000;80:354-7.
17. Mohanty D, Shetty S, Ghosh K, Pawar A, Abraham P. Hereditary thrombophilia as a cause of Budd-Chiari syndrome: a study from western India. Hepatology 2001;34:666-70.
18. Bhattacharyya M, Makharia G, Kannan M, Ahmed RP, Gupta PK, Saxena R. Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India. Am J Clin Pathol 2004;121:844-7.
19. Garewal G, Das R, Varma S, Chawla Y, Prabhakar S. Heterogeneous distribution of factor V Leiden in patients from north India with venous thromboembolism. J Thromb Haemost 2003;1:1329-30.
20. Garewal G, Das R, Ahluwalia J, Mittal N, Varma S. Prothrombin G20210A is not prevalent in northern India. J Thromb Haemost 2003;1:2253-4.
21. Aggarwal R, Ravishankar B, Misra R, Aggarwal A, Dwivedi S, Naik SR. Significance of elevated IgG anticardiolipin antibody levels in patients with Budd-Chiari syndrome. Am J Gastroenterol 1998;93:954-7.